Cargando…

A Comprehensive Prognostic and Immune Analysis of Ferroptosis-Related Genes Identifies SLC7A11 as a Novel Prognostic Biomarker in Lung Adenocarcinoma

Lung adenocarcinoma (LUAD) is still one of the illnesses with the greatest mortality and morbidity. As a recently identified mode of cellular death, the activation of ferroptosis may promote the effectiveness of antitumor therapies in several types of tumors. However, the expression and clinical sig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qian, Li, Wang, Fu, Lu, Shu-min, Miao, Hua-jie, He, Xin, Feng, Jia, Huang, Hua, Shi, Rong-feng, Zhang, Jian-guo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061045/ https://www.ncbi.nlm.nih.gov/pubmed/35509981 http://dx.doi.org/10.1155/2022/1951620

Ejemplares similares

Comprehensive analysis to identify GNG7 as a prognostic biomarker in lung adenocarcinoma correlating with immune infiltrates
por: Wei, Qin, et al.
Publicado: (2022)

Pan-Cancer Analyses Confirmed the Ferroptosis-Related Gene SLC7A11 as a Prognostic Biomarker for Cancer
por: Lin, Yi, et al.
Publicado: (2022)

Comprehensive Analysis of Ferroptosis Regulators in Lung Adenocarcinomas Identifies Prognostic and Immunotherapy-Related Biomarkers
por: Sun, Sijin, et al.
Publicado: (2021)

SLC7A11, a Potential Therapeutic Target Through Induced Ferroptosis in Colon Adenocarcinoma
por: Cheng, Xin, et al.
Publicado: (2022)

Ferroptosis-related gene SLC1A5 is a novel prognostic biomarker and correlates with immune infiltrates in stomach adenocarcinoma
por: Zhu, Dandan, et al.
Publicado: (2022)

Bulk RNA-seq and scRNA-seq reveal SLC7A11, a key regulatory molecule of ferroptosis, is a prognostic-related biomarker and highly related to the immune system in lung adenocarcinoma
por: Wu, Xiaoyu, et al.
Publicado: (2023)

METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m(6)A modification
por: Xu, Yiming, et al.
Publicado: (2022)

CircP4HB regulates ferroptosis via SLC7A11-mediated glutathione synthesis in lung adenocarcinoma
por: Pan, Chun-Feng, et al.
Publicado: (2022)

Bavachin Induces Ferroptosis through the STAT3/P53/SLC7A11 Axis in Osteosarcoma Cells
por: Luo, Yi, et al.
Publicado: (2021)

HBx facilitates ferroptosis in acute liver failure via EZH2 mediated SLC7A11 suppression
por: Liu, Guo-Zhen, et al.
Publicado: (2021)

Solute Carrier Family 7 Member 11 (SLC7A11) is a Potential Prognostic Biomarker in Uterine Corpus Endometrial Carcinoma
por: Fang, Xiangming, et al.
Publicado: (2023)

Tetrandrine citrate suppresses lung adenocarcinoma growth via SLC7A11/GPX4-mediated ferroptosis
por: Mo, Xiaocong, et al.
Publicado: (2023)

SLC7A7 is a prognostic biomarker correlated with immune infiltrates in non-small cell lung cancer
por: Dai, Wumin, et al.
Publicado: (2021)

Ferroptosis regulator SLC7A11 is a prognostic marker and correlated with PD-L1 and immune cell infiltration in liver hepatocellular carcinoma
por: Liang, Yimin, et al.
Publicado: (2022)

SLC7A5 is a lung adenocarcinoma-specific prognostic biomarker and participates in forming immunosuppressive tumor microenvironment
por: Liu, Yong, et al.
Publicado: (2022)

Capsaicin induces ferroptosis of NSCLC by regulating SLC7A11/GPX4 signaling in vitro
por: Liu, Xiao-Yan, et al.
Publicado: (2022)

SLC25A11 serves as a novel prognostic biomarker in liver cancer
por: Pan, Guoqiang, et al.
Publicado: (2020)

SLC7A11 as a Gateway of Metabolic Perturbation and Ferroptosis Vulnerability in Cancer
por: Lee, Jaewang, et al.
Publicado: (2022)

Nrf2 attenuates ferroptosis-mediated IIR-ALI by modulating TERT and SLC7A11
por: Dong, Hui, et al.
Publicado: (2021)

Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer
por: Yang, Jingjing, et al.
Publicado: (2021)

Levobupivacaine Induces Ferroptosis by miR-489-3p/SLC7A11 Signaling in Gastric Cancer
por: Mao, Shun-Hong, et al.
Publicado: (2021)

Arbutin alleviates fatty liver by inhibiting ferroptosis via FTO/SLC7A11 pathway
por: Jiang, Tianyu, et al.
Publicado: (2023)

Prognostic implications of ferroptosis-associated gene signature in colon adenocarcinoma
por: Miao, Yan-Dong, et al.
Publicado: (2021)

Prognostic value of ferroptosis‐related genes in patients with lung adenocarcinoma
por: Zhu, Guangsheng, et al.
Publicado: (2021)

SLC15A4 Serves as a Novel Prognostic Biomarker and Target for Lung Adenocarcinoma
por: Huang, Hui, et al.
Publicado: (2021)

Fibroblast Activation Protein-Alpha is a Prognostic Biomarker Associated With Ferroptosis in Stomach Adenocarcinoma
por: Lyu, Zejian, et al.
Publicado: (2022)

Nrf2 and STAT3 Alleviates Ferroptosis-Mediated IIR-ALI by Regulating SLC7A11
por: Qiang, Zhuanzhuan, et al.
Publicado: (2020)

Development and Validation of a Robust Ferroptosis-Related Prognostic Signature in Lung Adenocarcinoma
por: Zhang, Anran, et al.
Publicado: (2021)

SLC7A11 Reduces Laser-Induced Choroidal Neovascularization by Inhibiting RPE Ferroptosis and VEGF Production
por: Zhao, Xiaohuan, et al.
Publicado: (2021)

SLC7A11 regulated by NRF2 modulates esophageal squamous cell carcinoma radiosensitivity by inhibiting ferroptosis
por: Feng, Lei, et al.
Publicado: (2021)

Comprehensive Analysis Identified ETV7 as a Potential Prognostic Biomarker in Bladder Cancer
por: Li, Haimeng, et al.
Publicado: (2021)

TXNDC12 knockdown promotes ferroptosis by modulating SLC7A11 expression in glioma
por: Yu, Hao, et al.
Publicado: (2023)

CEBPG suppresses ferroptosis through transcriptional control of SLC7A11 in ovarian cancer
por: Zhang, Xiaoqian, et al.
Publicado: (2023)

Prognostic Modeling of Lung Adenocarcinoma Based on Hypoxia and Ferroptosis-Related Genes
por: Liu, Chang, et al.
Publicado: (2022)

miR-16-5p Regulates Ferroptosis by Targeting SLC7A11 in Adriamycin-Induced Ferroptosis in Cardiomyocytes
por: Chen, Yongquan, et al.
Publicado: (2023)

Prognostic Value of SLC4A4 and its Correlation with Immune Infiltration in Colon Adenocarcinoma
por: Chen, Xiaoli, et al.
Publicado: (2020)

Comprehensive Analysis of SLC17A9 and Its Prognostic Value in Hepatocellular Carcinoma
por: Kui, Xue-Yan, et al.
Publicado: (2022)

SLC7A11, a potential immunotherapeutic target in lung adenocarcinoma
por: Shan, Qingqing, et al.
Publicado: (2023)

Histone demethylase KDM3B protects against ferroptosis by upregulating SLC7A11
por: Wang, Yishu, et al.
Publicado: (2020)

LncRNA HEPFAL accelerates ferroptosis in hepatocellular carcinoma by regulating SLC7A11 ubiquitination
por: Zhang, Baofu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bpqpf4kdevu3penpdn2c186j28